Compare EMBJ & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EMBJ | PEN |
|---|---|---|
| Founded | 1969 | 2004 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | Aerospace | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.5B | 12.2B |
| IPO Year | N/A | 2015 |
| Metric | EMBJ | PEN |
|---|---|---|
| Price | $71.68 | $311.34 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 15 |
| Target Price | N/A | ★ $332.40 |
| AVG Volume (30 Days) | ★ 709.4K | 532.6K |
| Earning Date | 02-26-2026 | 02-17-2026 |
| Dividend Yield | ★ 0.60% | N/A |
| EPS Growth | N/A | ★ 367.34 |
| EPS | 0.45 | ★ 4.14 |
| Revenue | ★ $7,746,796,250.00 | $1,333,798,000.00 |
| Revenue This Year | N/A | $16.77 |
| Revenue Next Year | $13.05 | $14.12 |
| P/E Ratio | $158.28 | ★ $75.74 |
| Revenue Growth | ★ 31.44 | 14.61 |
| 52 Week Low | $36.79 | $221.26 |
| 52 Week High | $73.12 | $325.03 |
| Indicator | EMBJ | PEN |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 70.21 |
| Support Level | N/A | $290.00 |
| Resistance Level | N/A | $325.03 |
| Average True Range (ATR) | 0.00 | 10.69 |
| MACD | 0.00 | 0.46 |
| Stochastic Oscillator | 0.00 | 97.84 |
Embraer SA based in Sao Paulo, Brazil, manufacturer of jets. Its focus is to achieve customer satisfaction with and services addressing the commercial airline, executive jets, and defense and security markets. It has developed a customer-centric technology-driven portfolio of commercial aviation products and services that allows it to build long-term relationships with clients in the commercial aviation, executive jets, and defense and security markets. It operates through the various segments namely Commercial Aviation, Defense and Security, Executive Aviation, Service and Support, and Other Segments. The company generates maximum revenue from the Commercial Aviation segment.
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.